Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OTHER FINANCING ACTIVITIES
Other Financing Activities HALO - Halozyme Therapeutics, Inc.
31.1 M
LAST VALUE
58.14%
2 YEAR CAGR
17.43%
5 YEAR CAGR
16.45%
10 YEAR CAGR